Definition of Technical Development Matter


Technical Development Matter means any matter involving the Development of a Licensed Product in the Field, including, without limitation, the determination of clinical trial design and any Development and/or regulatory dispute referred to the Executive Officers pursuant to Section 4.10(b).

Examples of Technical Development Matter in a sentence

For the purposes of this Agreement, the term "Technical Development Matter" shall mean any dispute concerning a Party's refusal to approve a clinical trial proposed pursuant to Section 2.6(b).
Disputes, controversies and claims related to matters intended to be decided within the governance provisions of this Agreement set forth in Article 3 shall be resolved pursuant to Article 3 and, to the extent such matters constitute a Technical Development Matter, Section 10.4, except in each case to the extent any such dispute, controversy or claim constitutes a Legal Dispute, in which event the provisions of Section 10.3 shall apply.
For the purposes of this Agreement, the term Technical Development Matter shall mean (a) any matter involving the Development of a Licensed Product in the Field, including the determination of clinical trial design and any Development or regulatory dispute referred to the Executive Officers pursuant to Section 3.10(a)(iii) and (b) any dispute concerning a Partys refusal to approve a clinical trial proposed pursuant to Section 2.6(b).
The Executive Officers shall diligently and in good faith, attempt to resolve the referred dispute within five (5) Business Days of receiving such written notification, failing which, except for Legal Disputes (unless as jointly agreed by the Parties), either Party may by written notice to the other Party require the specific issue in dispute to be submitted for resolution by an Expert Panel pursuant to Section 10.4, if such dispute is with respect to a Technical Development Matter.
For the purposes of this Agreement, the term Technical Development Matter shall mean any dispute concerning a Partys refusal to approve a clinical trial proposed pursuant to Section 2.6(b).